Integral Health Asset Management, LLC Celldex Therapeutics, Inc. Transaction History
Integral Health Asset Management, LLC
- $850 Million
- Q3 2024
A detailed history of Integral Health Asset Management, LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Integral Health Asset Management, LLC holds 300,000 shares of CLDX stock, worth $7.81 Million. This represents 1.2% of its overall portfolio holdings.
Number of Shares
300,000Holding current value
$7.81 Million% of portfolio
1.2%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding CLDX
# of Institutions
207Shares Held
67.3MCall Options Held
1.69MPut Options Held
980K-
Wellington Management Group LLP Boston, MA9.24MShares$241 Million0.06% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$122 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.87MShares$101 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.46MShares$90.1 Million9.64% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.33MShares$86.8 Million1.99% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.22B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...